ATE244566T1 - Zusammensetzung mit ketanserin und carnitin zur behandlung von crps - Google Patents

Zusammensetzung mit ketanserin und carnitin zur behandlung von crps

Info

Publication number
ATE244566T1
ATE244566T1 AT99916036T AT99916036T ATE244566T1 AT E244566 T1 ATE244566 T1 AT E244566T1 AT 99916036 T AT99916036 T AT 99916036T AT 99916036 T AT99916036 T AT 99916036T AT E244566 T1 ATE244566 T1 AT E244566T1
Authority
AT
Austria
Prior art keywords
crps
carnitine
treatment
ketanserine
composition
Prior art date
Application number
AT99916036T
Other languages
English (en)
Inventor
Claudio Cavazza
Menotti Calvani
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE244566T1 publication Critical patent/ATE244566T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT99916036T 1998-04-10 1999-04-08 Zusammensetzung mit ketanserin und carnitin zur behandlung von crps ATE244566T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
PCT/IT1999/000084 WO1999052517A2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps

Publications (1)

Publication Number Publication Date
ATE244566T1 true ATE244566T1 (de) 2003-07-15

Family

ID=11379743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916036T ATE244566T1 (de) 1998-04-10 1999-04-08 Zusammensetzung mit ketanserin und carnitin zur behandlung von crps

Country Status (17)

Country Link
US (2) US6214884B1 (de)
EP (1) EP0994703B1 (de)
JP (1) JP4482163B2 (de)
KR (1) KR100573010B1 (de)
AT (1) ATE244566T1 (de)
AU (1) AU742013B2 (de)
BR (1) BR9906350A (de)
CA (1) CA2292638C (de)
DE (1) DE69909395T2 (de)
DK (1) DK0994703T3 (de)
ES (1) ES2203115T3 (de)
HK (1) HK1026608A1 (de)
IL (1) IL133141A (de)
IT (1) IT1299069B1 (de)
NZ (1) NZ501416A (de)
PT (1) PT994703E (de)
WO (1) WO1999052517A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084905A2 (en) * 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN1686139B (zh) * 2005-04-30 2012-07-11 福建师范大学 酮色林在治疗炎性疼痛的新型镇痛药中的应用
KR20240100931A (ko) 2022-12-23 2024-07-02 주식회사 일리아스바이오로직스 슈퍼-리프레서(super-repressor, SR)-IκB(srIκB)를 포함하는 엑소좀의 복합부위통증증후군에 대한 치료적 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism

Also Published As

Publication number Publication date
PT994703E (pt) 2003-11-28
US20040209906A1 (en) 2004-10-21
US6214884B1 (en) 2001-04-10
AU742013B2 (en) 2001-12-13
IT1299069B1 (it) 2000-02-07
DK0994703T3 (da) 2003-11-03
JP4482163B2 (ja) 2010-06-16
IL133141A0 (en) 2001-03-19
ES2203115T3 (es) 2004-04-01
HK1026608A1 (en) 2000-12-22
BR9906350A (pt) 2000-09-19
NZ501416A (en) 2002-03-01
AU3442699A (en) 1999-11-01
EP0994703A2 (de) 2000-04-26
DE69909395T2 (de) 2004-06-09
WO1999052517A3 (en) 2000-01-06
IL133141A (en) 2006-06-11
JP2002504934A (ja) 2002-02-12
CA2292638A1 (en) 1999-10-21
ITMI980774A1 (it) 1999-10-10
KR20010013685A (ko) 2001-02-26
KR100573010B1 (ko) 2006-04-24
EP0994703B1 (de) 2003-07-09
DE69909395D1 (de) 2003-08-14
CA2292638C (en) 2008-08-26
WO1999052517A2 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
CA2322311A1 (en) Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
ATE404522T1 (de) Lipoxinverbindungen und deren verwendung zur behandlung der zellenwucherungsstörung
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
SE9604786D0 (sv) New compounds
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
BR9708632A (pt) Composto calcilìticos
ATE275608T1 (de) Behandlung von mineralfüllstoffen mit phosphaten, diese füllstoffe und deren verwendung
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
PT799578E (pt) Preparacao combinada contendo germes enriquecidos com electrolitos
DE69834522D1 (de) Hochmolekulares Flockungsmittel, Verfahren zu dessen Herstellung und Verfahren zur Wasserbehandlung mit diesem Mittel
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
EE03420B1 (et) Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung
ATE244566T1 (de) Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
NO20003629D0 (no) Forbindelser med veksthormonfrigjørende egenskaper
ATE291468T1 (de) Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
ITRM920165A0 (it) Impiego di l-carnitina nel trattamento di pazienti hiv-sieropositivi presentanti deficit di carnitina.
NO994339L (no) Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat
CA2387394A1 (en) Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
MX9504335A (es) Uso de la sal de amina dietilica de ceruletida en el tratamiento de la psoriasis.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0994703

Country of ref document: EP